Ono Pharmaceutical , Ltd. Overview
Ono Pharmaceutical , Ltd. (OPHLY) has a ROE of 8.89%, below the sector sector average of 11.75%.
Get informed when a big investor buys or sells
+ Follow8.89%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
As of the most recent data, OPHLY shows a ROE of 8.89%. That is below the sector sector average of 11.75%. Scroll down for historical charts and peer comparison views.
The its sector sector average ROE is about 11.75%. Ono Pharmaceutical , Ltd. is at 8.89%, which is lower that average. That is roughly 24.4% below the sector mean. Use the comparison chart on this page to see how OPHLY stacks up against individual peers as well.
Check the historical chart to see whether OPHLY's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Ono Pharmaceutical , Ltd. with peers to see if the move is company-specific or sector-wide.
Besides this return on equity page, Stockcircle has Ono Pharmaceutical , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 8.89%) with ownership activity and broader fundamentals.
